
Gollamudi S. Kishore
Examiner (ID: 18204, Phone: (571)272-0598 , Office: P/1612 )
| Most Active Art Unit | 1612 |
| Art Unit(s) | 1502, 1503, 1612, 2899, 1615 |
| Total Applications | 3055 |
| Issued Applications | 1377 |
| Pending Applications | 265 |
| Abandoned Applications | 1411 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 16776390
[patent_doc_number] => 20210113467
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-22
[patent_title] => METHODS FOR THE MANUFACTURE OF LIPOSOMAL DRUG FORMULATIONS
[patent_app_type] => utility
[patent_app_number] => 17/052070
[patent_app_country] => US
[patent_app_date] => 2019-05-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6093
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -34
[patent_words_short_claim] => 104
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17052070
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/052070 | METHODS FOR THE MANUFACTURE OF LIPOSOMAL DRUG FORMULATIONS | May 1, 2019 | Abandoned |
Array
(
[id] => 16913786
[patent_doc_number] => 20210186878
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-24
[patent_title] => MULTI-VESICULAR LIPOSOMES FOR TARGETED DELIVERY OF DRUGS AND BIOLOGICS FOR TISSUE ENGINEERING
[patent_app_type] => utility
[patent_app_number] => 17/050556
[patent_app_country] => US
[patent_app_date] => 2019-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7292
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17050556
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/050556 | Multi-vesicular liposomes for targeted delivery of drugs and biologics for tissue engineering | Apr 28, 2019 | Issued |
Array
(
[id] => 18084292
[patent_doc_number] => 11534399
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-12-27
[patent_title] => Inhalable liposomal sustained release composition for use in treating pulmonary diseases
[patent_app_type] => utility
[patent_app_number] => 17/045940
[patent_app_country] => US
[patent_app_date] => 2019-04-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 8063
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 91
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17045940
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/045940 | Inhalable liposomal sustained release composition for use in treating pulmonary diseases | Apr 22, 2019 | Issued |
Array
(
[id] => 14712447
[patent_doc_number] => 20190247287
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-15
[patent_title] => COMPOSITIONS AND METHODS FOR IMPROVED SKIN CARE
[patent_app_type] => utility
[patent_app_number] => 16/390604
[patent_app_country] => US
[patent_app_date] => 2019-04-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16809
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16390604
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/390604 | COMPOSITIONS AND METHODS FOR IMPROVED SKIN CARE | Apr 21, 2019 | Abandoned |
Array
(
[id] => 17050533
[patent_doc_number] => 20210259967
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-26
[patent_title] => TREATMENT OF SEPSIS AND SEPTIC SHOCK
[patent_app_type] => utility
[patent_app_number] => 17/048909
[patent_app_country] => US
[patent_app_date] => 2019-04-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10657
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17048909
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/048909 | TREATMENT OF SEPSIS AND SEPTIC SHOCK | Apr 17, 2019 | Abandoned |
Array
(
[id] => 17814300
[patent_doc_number] => 11419887
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-08-23
[patent_title] => Vehicle for delivering a compound to a mucous membrane and related compositions, methods and systems
[patent_app_type] => utility
[patent_app_number] => 16/386522
[patent_app_country] => US
[patent_app_date] => 2019-04-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 27
[patent_no_of_words] => 16373
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 79
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16386522
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/386522 | Vehicle for delivering a compound to a mucous membrane and related compositions, methods and systems | Apr 16, 2019 | Issued |
Array
(
[id] => 16612024
[patent_doc_number] => 20210030677
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-04
[patent_title] => TREATMENT OF PNEUMONIA
[patent_app_type] => utility
[patent_app_number] => 17/047666
[patent_app_country] => US
[patent_app_date] => 2019-04-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9309
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 100
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17047666
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/047666 | Treatment of pneumonia | Apr 15, 2019 | Issued |
Array
(
[id] => 16761017
[patent_doc_number] => 20210106598
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-15
[patent_title] => PHYTATES FOR USE AS A BIOMOLECULES DELIVERY OR ADSORPTION SYSTEM
[patent_app_type] => utility
[patent_app_number] => 17/044768
[patent_app_country] => US
[patent_app_date] => 2019-04-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6321
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17044768
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/044768 | Phytates for use as a biomolecules delivery or adsorption system | Apr 9, 2019 | Issued |
Array
(
[id] => 15114267
[patent_doc_number] => 20190343766
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-11-14
[patent_title] => MEDICAL USE OF SPLA2 HYDROLYSABLE LIPOSOMES
[patent_app_type] => utility
[patent_app_number] => 16/360836
[patent_app_country] => US
[patent_app_date] => 2019-03-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8072
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16360836
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/360836 | Medical use of sPLA2 hydrolysable liposomes | Mar 20, 2019 | Issued |
Array
(
[id] => 14833201
[patent_doc_number] => 20190275001
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-09-12
[patent_title] => SUNITINIB FORMULATIONS AND METHODS FOR USE THEREOF IN TREATMENT OF OCULAR DISORDERS
[patent_app_type] => utility
[patent_app_number] => 16/357195
[patent_app_country] => US
[patent_app_date] => 2019-03-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21397
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16357195
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/357195 | SUNITINIB FORMULATIONS AND METHODS FOR USE THEREOF IN TREATMENT OF OCULAR DISORDERS | Mar 17, 2019 | Abandoned |
Array
(
[id] => 14531827
[patent_doc_number] => 20190201534
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-07-04
[patent_title] => SUSTAINED RELEASE OF ANTIINFECTIVES
[patent_app_type] => utility
[patent_app_number] => 16/297027
[patent_app_country] => US
[patent_app_date] => 2019-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18834
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -85
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16297027
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/297027 | SUSTAINED RELEASE OF ANTIINFECTIVES | Mar 7, 2019 | Abandoned |
Array
(
[id] => 18328144
[patent_doc_number] => 11633357
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-04-25
[patent_title] => Liposome formulation and manufacture
[patent_app_type] => utility
[patent_app_number] => 16/289775
[patent_app_country] => US
[patent_app_date] => 2019-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 6
[patent_no_of_words] => 10551
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16289775
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/289775 | Liposome formulation and manufacture | Feb 28, 2019 | Issued |
Array
(
[id] => 15035321
[patent_doc_number] => 20190328665
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-31
[patent_title] => LIPOSOME COMPOSITIONS ENCAPSULATING MODIFIED CYCLODEXTRIN COMPLEXES AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/288826
[patent_app_country] => US
[patent_app_date] => 2019-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15511
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16288826
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/288826 | LIPOSOME COMPOSITIONS ENCAPSULATING MODIFIED CYCLODEXTRIN COMPLEXES AND USES THEREOF | Feb 27, 2019 | Abandoned |
Array
(
[id] => 18947079
[patent_doc_number] => 11890352
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-02-06
[patent_title] => Plectin-targeted liposomes/PARP inhibitor in the treatment of cancer
[patent_app_type] => utility
[patent_app_number] => 16/971095
[patent_app_country] => US
[patent_app_date] => 2019-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 26
[patent_no_of_words] => 23151
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16971095
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/971095 | Plectin-targeted liposomes/PARP inhibitor in the treatment of cancer | Feb 26, 2019 | Issued |
Array
(
[id] => 16466637
[patent_doc_number] => 20200368174
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-11-26
[patent_title] => PARTICLES FOR TARGETED DELIVERY OF ACTIVE AGENTS INTO ADIPOSE STROMAL CELLS
[patent_app_type] => utility
[patent_app_number] => 16/966310
[patent_app_country] => US
[patent_app_date] => 2019-02-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21291
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16966310
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/966310 | PARTICLES FOR TARGETED DELIVERY OF ACTIVE AGENTS INTO ADIPOSE STROMAL CELLS | Feb 20, 2019 | Abandoned |
Array
(
[id] => 16776403
[patent_doc_number] => 20210113480
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-22
[patent_title] => COMPOSITION FOR INCREASING EXPRESSION OF BLOOD COAGULATION FACTOR GENE, COMPRISING CORE-SHELL STRUCTURED MICROPARTICLES AS ACTIVE INGREDIENT
[patent_app_type] => utility
[patent_app_number] => 16/969040
[patent_app_country] => US
[patent_app_date] => 2019-02-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5748
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16969040
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/969040 | COMPOSITION FOR INCREASING EXPRESSION OF BLOOD COAGULATION FACTOR GENE, COMPRISING CORE-SHELL STRUCTURED MICROPARTICLES AS ACTIVE INGREDIENT | Feb 11, 2019 | Abandoned |
Array
(
[id] => 14403391
[patent_doc_number] => 20190167539
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-06
[patent_title] => DMS (derma membrane structure) in Foam Creams
[patent_app_type] => utility
[patent_app_number] => 16/270929
[patent_app_country] => US
[patent_app_date] => 2019-02-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7417
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -31
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16270929
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/270929 | DMS (derma membrane structure) in Foam Creams | Feb 7, 2019 | Abandoned |
Array
(
[id] => 14372349
[patent_doc_number] => 20190160087
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-30
[patent_title] => SUSTAINED RELEASE OF ANTIINFECTIVES
[patent_app_type] => utility
[patent_app_number] => 16/264865
[patent_app_country] => US
[patent_app_date] => 2019-02-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7781
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16264865
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/264865 | SUSTAINED RELEASE OF ANTIINFECTIVES | Jan 31, 2019 | Abandoned |
Array
(
[id] => 14338541
[patent_doc_number] => 20190151243
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-23
[patent_title] => COMPOSITION OF MATTER COMPRISING LIPOSOMES EMBEDDED IN A POLYMERIC MATRIX AND METHODS OF USING SAME
[patent_app_type] => utility
[patent_app_number] => 16/254084
[patent_app_country] => US
[patent_app_date] => 2019-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21203
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 164
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16254084
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/254084 | Composition of matter comprising liposomes embedded in a polymeric matrix and methods of using same | Jan 21, 2019 | Issued |
Array
(
[id] => 18215167
[patent_doc_number] => 11590079
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-02-28
[patent_title] => Treating microvascular dysfunction
[patent_app_type] => utility
[patent_app_number] => 16/962956
[patent_app_country] => US
[patent_app_date] => 2019-01-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 12
[patent_no_of_words] => 15397
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 85
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16962956
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/962956 | Treating microvascular dysfunction | Jan 17, 2019 | Issued |